CollPlant Biotechnologies Ltd. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD -13.57 M

CollPlant Biotechnologies Ltd. EBITDA is USD -13.57 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 87.92% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • CollPlant Biotechnologies Ltd. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -7.22 M, a -54.11% change year over year.
  • CollPlant Biotechnologies Ltd. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -15.73 M, a 22.68% change year over year.
  • CollPlant Biotechnologies Ltd. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -12.82 M, a -289.06% change year over year.
  • CollPlant Biotechnologies Ltd. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 6.78 M, a -199.44% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)